DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Moban (Molindone Hydrochloride) - Published Studies

 
 



Moban Related Published Studies

Well-designed clinical trials related to Moban (Molindone)

D-cycloserine adjuvant therapy to molindone in the treatment of schizophrenia. [1996.10]

A comparison of masking effects of haloperidol versus molindone in tardive dyskinesia. [1990.10]

Well-designed clinical trials possibly related to Moban (Molindone)

Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study. [2012]

Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study. [2010]

Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. [2008.11]

Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. [2006.09]

Expected incidence of tardive dyskinesia associated with atypical antipsychotics. [2000]

L-tyrosine pharmacotherapy of schizophrenia: preliminary data. [1994.02]

Thioridazine improves affective symptoms in schizophrenic patients. [1993]

Other research related to Moban (Molindone)

Molindone for schizophrenia and severe mental illness. [2007.01.24]

Molindone for schizophrenia and severe mental illness. [2000]

Treatment of clozapine- and molindone-induced agranulocytosis with granulocyte colony-stimulating factor. [1993.10]

The use of molindone in the treatment of psychotic and delirious patients infected with the human immunodeficiency virus. Case reports. [1993.01]

Neuroleptic malignant syndrome possibly caused by molindone hydrochloride. [1991.10]

Polydipsia and hyponatremia induced by multiple neuroleptics but not molindone. [1990.04]

Relation of serum molindone levels to serum prolactin levels and antipsychotic response. [1989.10]

Reinstitution of neuroleptic treatment with molindone in a patient with a history of neuroleptic malignant syndrome. [1989.09]

Molindone hydrochloride: a review of laboratory and clinical findings. [1989.08]

Other possibly related research studies

Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis. [2005.01.01]

Tissue distribution of molidone in a multidrug overdose. [2004.09]

Antipsychotic-induced weight gain: a comprehensive research synthesis. [1999.11]

Psychosis during pregnancy: treatment considerations. [1997.09]

Famotidine adjunctive pharmacotherapy of schizophrenia: a case report. [1995.08]

Basal ganglia iron in tardive dyskinesia: an MRI study. [1994.01.01]

Neuroleptic-induced "painful legs and moving toes" syndrome: successful treatment with clonazepam and baclofen. [1990.12]

Antipsychotic medication and seizures: a review. [2003.07]

Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives. [2002.11]

[Body weight changes and psychotropic drug treatment: neuroleptics] [2001.05]

Weight gain associated with antipsychotic drugs. [1999]

Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. [1998.03]

Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. [1996.05]

Emergency treatment of psychotic symptoms. Pharmacokinetic considerations for antipsychotic drugs. [1995.06]

The clinical impact of reported variance in potency of antipsychotic agents. [1995.04]

Weight gain associated with neuroleptic medication: a review. [1995]

Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. [1994.11]

Fluoxetine ingestion: a one year retrospective study. [1990.04]

Which atypical antipsychotics are identified by screening tests? [1989.06]

Successful use of clozapine in a patient with a history of neuroleptic malignant syndrome. [1989.06]

The possible role of dopamine autoreceptors in neuroleptic atypicality. [1988.03]

Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients. [2006.11]

Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia. [2006.01.25]

Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS): Rationale, Design, and Methods. [2007.08]

Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients. [2008.10]

Treatment of early-onset schizophrenia. [2010.07]

Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study. [2010.06]

Atypical antipsychotics for psychosis in adolescents. [2013]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017